Age-Associated Increases In PAI-1 Silenced With Sirna-Lipid Nanoparticles Reduces Thrombosis And Prolongs Lifespan
As we age, our bodies undergo many changes, and one protein, called plasminogen activator inhibitor 1 (PAI-1), tends to increase. High levels of this protein are linked to a higher risk of developing blood clots, a condition known as thrombosis, and are also associated with various age-related health issues like diabetes, cancer, and even Alzheimer’s disease. Conversely, individuals with naturally lower levels of this protein often show protection against cardiovascular problems and tend to live longer.
Scientists have been exploring ways to safely lower the amount of this protein in the body. A recent study investigated a novel therapeutic approach using tiny fat-based particles, known as lipid nanoparticles, to deliver small interfering RNA (siRNA). This specialized genetic material is designed to “silence” or “knock down” the gene responsible for producing PAI-1, thereby reducing its circulating levels.
The findings were promising: a single administration of these siRNA-lipid nanoparticles effectively reduced PAI-1 levels by a significant amount, with the effect lasting for an extended period without any noticeable harmful side effects. More importantly, this reduction in the protein led to a decrease in the formation of blood clots in both younger and older mice. Furthermore, in a model of accelerated aging, the treatment was shown to prolong the animals’ lifespan.
This research suggests that targeting and reducing this age-associated protein could be a valuable long-term strategy for preventing dangerous blood clots and potentially mitigating some of the detrimental health effects associated with aging and age-related diseases.
Source: link to paper